|
1）Furukawa K, Takamiya K, Okada M, et al. Novel functions of complex carbohydrates elucidated by the mutant mice of glycosyltransferase genes. Biochim Biophys Acta. 2001; 1525: 1-12
|
|
|
|
2）Takamiya K, Yamamoto A, Furukawa K, et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A. 1996; 93: 10662-7
|
|
|
|
|
3）Okada M, Itoh Mi, M, Haraguchi M, et al. b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem. 2002; 277:1633-6
|
|
|
|
|
|
4）Ohmi Y, Tajima O, Ohkawa Y, et al. Gangliosides play pivotal roles in the regulation of comple-ment systems and in the maintenance of integrity in nerve tissues. Proc Natl Acad Sci U S A. 2009; 106: 22405-10
|
|
|
|
|
|
5）Ohmi Y, Tajima O, Ohkawa Y, et al. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem. 2011; 116: 926-35
|
|
|
|
|
|
6）Ohmi Y, Ohkawa Y, Yamauchi Y, et al. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues. Neurochem Res. 2012; 37: 1185-91
|
|
|
|
|
|
7）Nakatani Y, Yanagisawa M, Suzuki Y, et al. Characterization of GD3 ganglioside as a novel biomarker of mouse neural stem cells. Glyco-biology. 2010; 20: 78-86
|
|
|
|
|
|
8）Ohkawa Y, Miyazaki S, Hamamura K, et al. Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem. 2010; 285: 27213-23
|
|
|
|
|
|
9）Hamamura K, Tsuji M, Hotta H, et al. Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J Biol Chem. 2011; 286: 18526-37
|
|
|
|
|
|
10）Yanagisawa K. Role of gangliosides in Alzheimers disease. Biochim Biophys Acta. 2007; 1768: 1943-51
|
|
|
|
|
|
11）Matsuzaki K, Kato K, Yanagisawa K. Abeta polymerization through interaction with mem-brane gangliosides. Biochim Biophys Acta. 2010; 1801: 868-77
|
|
|
|
|
|
12）Yuyama K, Yamamoto N, Yanagisawa K. Accelerated release of exosome-associated GM1 ganglioside (GM1) by endocytic pathway abnormality: another putative pathway for GM1-induced amyloid fibril formation. J Neurochem. 2008; 105: 217-24
|
|
|
|
|
|
13）Oikawa N, Yamaguchi H, Ogino K, et al. Gangliosides determine the amyloid pathology of Alzheimers disease. Neuroreport. 2009; 20: 1043-6
|
|
|
|
|
|
14）Bernardo A, Harrison FE, McCord M, et al. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in trans-genic mice. Neurobiol Aging. 2009; 30: 1777-91
|
|
|
|
|
|
15）Grimm MO, Zinser EG, Grosgen S, et al. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimers disease pathology with ganglioside metabolism. PLoS One. 2012; 7: e34095
|
|
|
|
|
|
16）Simpson MA, Cross H, Proukakis C, et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function muta-tion of GM3 synthase. Nat Genet. 2004; 36: 1225-9
|
|
|
|
|
|
17）Aoki K, Boccuto L, Kulik M, et al. Glycomic analysis of cell lineages derived from Salt-and Pepper Syndrome iPS cells. The 31th Japanese Carbohydrate Symposium. Kagoshima, Japan, 2012, 9
|
|
|
|
|
|
18）Yamashita T, Hashiramoto A, Haluzik M, et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A. 2003; 100: 3445-9
|
|
|
|
|
|
19）Fukuda T, Hashimoto H, Okayasu N, et al. Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems. J Biol Chem. 2011; 286: 18434-43
|
|
|
|
|
|
20）Isomura R, Kitajima K, Sato C. Structural and functional impairments of polysialic acid by a mutated polysialyltransferase found in schizo-phrenia. J Biol Chem. 2011; 286: 21535-45
|
|
|
|
|
|
21）Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyl-transferase, POMGnT1. Dev Cell. 2001; 1: 717-24
|
|
|
|
|
|
22）Yoshida-Moriguchi T, Yu L, Stalnaker SH, et al. O-mannosyl phosphorylation of alpha-dystro-glycan is required for laminin binding. Science. 2010; 327: 88-92
|
|
|
|
|
|
23）Inamori K, Yoshida-Moriguchi T, Hara Y, et al. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science. 2012; 335: 93-6
|
|
|
|
|
|
24）Nakagawa N, Manya H, Toda T, et al. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-Dystroglycan. J Biol Chem. 2012; 287: 30823-32
|
|
|
|
|
|
25）Willer T, Lee H, Lommel M, et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet. 2012; 44: 575-80
|
|
|
|
|
|
26）Roscioli T, Kamsteeg EJ, Buysse K, et al. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan. Nat Genet. 2012; 44: 581-5
|
|
|
|
|
|
27）Manzini MC, Tambunan DE, Hill RS, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet. 2012; 91: 541-7
|
|
|
|
|
|
28）Bradbury EJ, Moon LD, Popat RJ, et al. Chon-droitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002; 416: 636-40
|
|
|
|
|
|
29）Imagama S, Sakamoto K, Tauchi R, et al. Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci. 2011; 31: 17091-102
|
|
|
|
|
|
30）Miyata S, Komatsu Y, Yoshimura Y, et al. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci. 2012; 15: 414-22, S1-2
|
|
|
|
|